Research programme: TLR9 agonists - PfizerAlternative Names: CpG 10104; CpG-ODN; TLR9 agonists research programme - Pfizer; Toll-like receptor 9 agonists - Pfizer
Latest Information Update: 22 Jul 2010
At a glance
- Originator Coley Pharmaceutical Group
- Mechanism of Action Toll-like receptor 9 agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Cancer; Viral infections
Most Recent Events
- 13 Aug 2009 This programme is still in active development
- 01 Apr 2004 Preclinical trials in Cancer in USA (unspecified route)